|By Marketwired .||
|April 11, 2014 04:38 PM EDT||
TEANECK, NJ -- (Marketwired) -- 04/11/14 -- Phibro Animal Health Corporation (NASDAQ: PAHC) (the "Company") today announced the pricing of its initial public offering of 12,745,392 shares of Class A Common Stock ("Class A Common Stock") at a price to the public of $15.00 per share. The shares are being offered by the Company and a selling stockholder, Mayflower Limited Partnership ("Mayflower"), whose sole limited partner is 3i Group plc ("3i Group"). The gross proceeds from the offering will be approximately $125 million for the Company and approximately $66 million for 3i Group. In addition, Mayflower has granted the underwriters a 30 day option to purchase up to an additional 1,911,808 shares of Class A Common Stock to cover over-allotments, if any. The shares began trading on April 11, 2014 on The NASDAQ Global Market under the ticker symbol "PAHC." The closing of the offering is expected to occur on April 16, 2014, subject to the satisfaction of customary closing conditions.
BofA Merrill Lynch, Morgan Stanley and Barclays are serving as joint book-running managers for the offering; Guggenheim Securities, Macquarie Capital, and Cantor Fitzgerald & Co. are acting as co-managers for the offering. Perella Weinberg Partners is acting as advisor to the Company.
The offer is being made only by means of a prospectus. Copies of the prospectus may be obtained from: BofA Merrill Lynch, Attention: Prospectus Department, 222 Broadway, New York, New York 10038, or by email: [email protected], Morgan Stanley, Attention: Prospectus Department, 180 Varick Street, 2nd Floor, New York, New York 10014, and Barclays, (c/o Broadridge Financial Solutions) 1155 Long Island Avenue, Edgewood, New York 11717, via telephone: +1 (888).603-5847 or by email: [email protected].
A registration statement relating to shares of the Class A Common Stock of the Company was declared effective by the Securities and Exchange Commission on April 10, 2014. This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor may there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
About Phibro Animal Health Corporation
Phibro Animal Health Corporation is a diversified global developer, manufacturer and marketer of a broad range of animal health and mineral nutrition products for use in the production of poultry, swine, cattle, dairy and aquaculture.
For further information, please visit www.pahc.com.
About 3i Group
3i is a leading international investor focused on mid-market private equity, infrastructure and debt management across Europe, Asia and the Americas.
For further information, please visit: www.3i.com.
Chief Financial Officer